About Us
Adler Therapeutics is an ophthalmology-focused specialty pharmaceutical company dedicated to developing high-quality therapeutic solutions that support the evolving needs of eye care.
Combining clinical insight, pharmaceutical science, and focused development, we are committed to advancing differentiated therapies grounded in safety, quality, and consistency.
Beyond Therapeutics
Our vision extends beyond individual products. We aim to build an integrated therapeutic ecosystem that evolves alongside modern clinical practice, offering solutions that complement clinicians and support better patient care.
Driven by Expertise
Backed by experienced professionals in pharmaceutical development and ophthalmology, Adler Therapeutics brings together specialized knowledge and a commitment to innovation to help shape the future of vision care.
Our Approach
Built around the needs of ophthalmic care.
At Adler, we believe developing meaningful therapies requires more than identifying a product opportunity. It requires understanding the people who deliver care, the patients who rely on it and the realities of modern ophthalmic practice.
Our approach brings together scientific expertise, clinical understanding and thoughtful development to shape therapeutic solutions around these needs. We work collaboratively throughout the product lifecycle, with careful consideration of quality, safety and the practical realities of clinical care.
At every stage, we remain focused on developing consistent, purposeful therapies that integrate naturally into clinical practice, with the broader aim of creating healthier vision and supporting better care for patients.
01
Discover
Understanding clinical needs and identifying opportunities for differentiated therapeutic development.
02
Develop
Working with scientific, clinical and pharmaceutical experts to shape purposeful therapeutic solutions.
03
Validate
Applying rigorous quality, clinical and non-clinical evaluation throughout product development.
04
Deliver
Bringing approved therapies to healthcare professionals and patients through a reliable path to access.
Focused science. Thoughtful development. Consistent quality.
Partner with us.
Science is where innovation begins. Access is where it makes a difference.
Adler partners with pharmaceutical companies, innovators and scientific organizations to advance ophthalmic therapies and expand what's available to Canadian patients. We bring regional expertise, healthcare access and a strong understanding of the regulatory and market access landscape, providing a focused pathway for bringing therapies into the Canadian market.
Our partners bring product expertise, consistent quality and reliable supply. Combining these complementary strengths allows Adler and its partners to move promising therapies from development toward patient access, with a shared commitment to quality, consistency and care.
From product introduction through ongoing lifecycle development, we work collaboratively to navigate the complexities of the Canadian healthcare environment and build partnerships designed for long-term impact.
Explore what we can build together.
Let’s connect and discuss how our complementary expertise can help expand access to ophthalmic therapies in Canada.